5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide,
ataciguat,
HMR 1766,
HMR-1766,
HMR1766,
Ataciguat,
254877-67-3,
HMR-1766,
UNII-QP166M390Q,
5-Chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide,
QP166M390Q,
5-chloro-2-[(5-chlorothiophen-2-yl)sulfonylamino]-N-(4-morpholin-4-ylsulfonylphenyl)benzamide,
DSSTox_CID_28672,
DSSTox_RID_82942,
Ataciguat [INN],
DSSTox_GSID_48746,
HMR 1766,
CAS-254877-67-3,
HMR1766,
AC1L4U4P,
AC1Q6UV8,
SCHEMBL491675,
GTPL5141,
CHEMBL2107729,
DTXSID7048746,
ZINC3612878,
Tox21_113203,
AKOS027326819,
Tox21_113203_1,
API0008114,
DB12805,
SB16944,
5-Chloro-2-((5-chloro-2-thienyl)sulfonylamino)-N-(4-(morpholin-4-ylsulfonyl)phenyl)benzamide,
NCGC00249417-01,
NCGC00249417-02,
ACM254877673,
FT-0662311,
J-016012,
5-chloro-2-(5-chlorothiophene-2-sulfonamido)-N-[4-(morpholine-4-sulfonyl)phenyl]benzamide,
D0C2ZL,
C21H19Cl2N3O6S3,
AR-1G7683,
CID213037,
C21-H19-Cl2-N3-O6-S3,
C515616,
30804-69-4,
5-chloro-2-{[(5-chlorothiophen-2-yl)sulfonyl]amino}-N-[4-(morpholin-4-ylsulfonyl)phenyl]benzamide,
Benzamide, 5-chloro-2-(((5-chloro-2-thienyl)sulfonyl)amino)-N-(4-(4-morpholinylsulfonyl)phenyl)-,